J Dawn Waters

Summary

Publications

  1. pmc Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions
    J Dawn Waters
    Division of Neurosurgery, University of California, San Diego, USA Center for Theoretic and Applied Neuro Oncology, University of California, San Diego, USA
    Surg Neurol Int 4:S176-81. 2013
  2. doi request reprint CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
    J Dawn Waters
    Division of Neurosurgery, University of California San Diego, La Jolla, CA 92093, USA
    J Neurooncol 110:37-48. 2012
  3. ncbi request reprint Malignancies of the spinal cord
    J Dawn Waters
    Division of Neurosurgery, University of California San Diego Medical Center San Diego, California, USA
    Adv Exp Med Biol 760:101-13. 2012
  4. doi request reprint Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma
    J Dawn Waters
    Division of Neurosurgery, Center for Theoretic and Applied Neuro Oncology, University of California, San Diego, 3855 Health Science Drive 0987, La Jolla, CA 92093 0987, USA
    J Neurooncol 113:467-77. 2013

Detail Information

Publications4

  1. pmc Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions
    J Dawn Waters
    Division of Neurosurgery, University of California, San Diego, USA Center for Theoretic and Applied Neuro Oncology, University of California, San Diego, USA
    Surg Neurol Int 4:S176-81. 2013
    ..Here we examine whether stereotactic biopsy of smaller brain lesions, defined for this study as being less than 1 cubic centimeter (1 cc) in volume, are associated with lowered diagnostic yield...
  2. doi request reprint CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
    J Dawn Waters
    Division of Neurosurgery, University of California San Diego, La Jolla, CA 92093, USA
    J Neurooncol 110:37-48. 2012
    ..These pre-clinical results provide the foundation to further understand long term response and tumor escape mechanisms to anti-angiogenic treatments on EGFR over-expressing glioblastomas...
  3. ncbi request reprint Malignancies of the spinal cord
    J Dawn Waters
    Division of Neurosurgery, University of California San Diego Medical Center San Diego, California, USA
    Adv Exp Med Biol 760:101-13. 2012
    ..This section will review the pathophysiology and epidemiology of IMSCT and the state-of-the-art management before delving into the promising new tools and techniques for each phase of management...
  4. doi request reprint Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma
    J Dawn Waters
    Division of Neurosurgery, Center for Theoretic and Applied Neuro Oncology, University of California, San Diego, 3855 Health Science Drive 0987, La Jolla, CA 92093 0987, USA
    J Neurooncol 113:467-77. 2013
    ..This case series demonstrates the safety of immediate post-operative brachytherapy when applied prior to EBRT and temozolomide in the treatment of newly diagnosed glioblastomas...